Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05968963 · ClinicalTrials.gov registry record · NA

Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation

A NA study of Myelodysplastic Syndromes and Lymphoma, Non-Hodgkin, sponsored by University of Miami.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05968963: Active NA study of Myelodysplastic Syndromes and Lymphoma, Non-Hodgkin, sponsored by University of Miami.

NCT05968963 is a NA study of Myelodysplastic Syndromes and Lymphoma, Non-Hodgkin that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 60 participants, below the 285-participant average among 173 other Myelodysplastic Syndromes trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05968963, a NA study of Myelodysplastic Syndromes and Lymphoma, Non-Hodgkin, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to pilot test an Electronic Health Mindfulness-based Music Therapy Intervention (eMBMT) intervention to improve health-related quality of life (HRQoL) and reduce symptom burden of patients undergoing allogeneic stem cell transplantation (allo-SCT).

Primary Outcome

Recruitment will be measured by the count of participants successfully enrolled and randomized into the study.

Conditions Studied

Myelodysplastic Syndromes Lymphoma, Non-Hodgkin Leukemia, Myeloid, Acute Stem Cell Transplantation Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

  • BEHAVIORAL Mindfulness-based Music Therapy (MBMT)
  • BEHAVIORAL Mindfulness Meditation (MM)

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-11-28
Est. Completion 2026-06-01
Phase NA
University of Miami

721 total trials

What the registry record for NCT05968963 still lists

NCT05968963 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 285-participant average among 173 other Myelodysplastic Syndromes trials with a reported enrollment target (79% lower).

The record links to 5 conditions, with Myelodysplastic Syndromes appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-based Music Therapy (MBMT) is the first listed.

NCT05968963 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05968963 about?

NCT05968963 is a clinical study titled "Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation". The goal of this study is to pilot test an Electronic Health Mindfulness-based Music Therapy Intervention (eMBMT) intervention to improve health-related quality of life (HRQoL) and reduce symptom burden of patients undergoing allogeneic stem cell transplantation (allo-SCT).

What is the current status of trial NCT05968963?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-11-28. Estimated completion is 2026-06-01.

What conditions does trial NCT05968963 study?

This clinical trial studies the following conditions: Myelodysplastic Syndromes, Lymphoma, Non-Hodgkin, Leukemia, Myeloid, Acute, Stem Cell Transplantation, Precursor Cell Lymphoblastic Leukemia-Lymphoma.

What interventions are being tested in trial NCT05968963?

The interventions under investigation include: Mindfulness-based Music Therapy (MBMT) (BEHAVIORAL), Mindfulness Meditation (MM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05968963?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05968963 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myelodysplastic Syndromes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05968963's enrollment target sits among peer trials

60 75th of 173 higher than 96 of 173 other Myelodysplastic Syndromes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myelodysplastic Syndromes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05968963, the US trial registry maintained by the National Library of Medicine. NCT05968963 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.